Positive results from Phase III study of Gazyva in follicular lymphoma
27 May 2016 | By Victoria White, Digital Content Producer
Roche has announced positive results from the pivotal Phase III GALLIUM study.
List view / Grid view
News
Researchers develop technology for printed personalised medicine
Researchers from the National University of Singapore have found a way to make personalised medicine cheaper and easier.
EMDAC recommends NDA approval for Sanofi’s type 2 diabetes treatment
26 May 2016 | By Victoria White, Digital Content Producer
The FDA's EMDAC has recommended the approval of the NDA for the fixed-ratio combination of insulin glargine and lixisenatide...
Managed Access Program for sickle cell disease treatment, PGLG
26 May 2016 | By Victoria White, Digital Content Producer
A Managed Access Program (MAP) for the treatment of sickle cell disease has been announced for Emmaus’ pharmaceutical grade L-glutamine treatment (PGLG)...
Safety follow-up completed for third dose level of NKR-2 trial
26 May 2016 | By Victoria White, Digital Content Producer
Celyad has completed the safety follow-up of the third dose level cohort in its Phase I/IIa clinical trial of its NKR-2 T-cell therapy...
NICE recommends Jevtana for advanced prostate cancer
25 May 2016 | By Victoria White, Digital Content Producer
Jevtana has been recommended in combination with other drugs as a treatment option for metastatic hormone-relapsed prostate cancer in England...
Vasculitis drug CCX168 to address major unmet needs, says GlobalData
25 May 2016 | By Victoria White, Digital Content Producer
ChemoCentryx’s CCX168 has strong potential to address major unmet needs in the vasculitis space, according to an analyst with GlobalData...
Sanofi files consent solicitation to replace Medivation’s Board
25 May 2016 | By Victoria White, Digital Content Producer
Sanofi says it had 'no choice' but to commence a process to elect eight independent directors who are more open to evaluating Sanofi's takeover proposal...
Clinical remission data for Stelara in Crohn’s disease presented at DDW
25 May 2016 | By Victoria White, Digital Content Producer
Data shows that a greater proportion of adult patients with Crohn's disease receiving Stelara SC maintenance therapy were in clinical remission at one year...
NICE recommends three type 2 diabetes treatments
25 May 2016 | By Victoria White, Digital Content Producer
NICE has published final guidance recommending three drugs for treating type 2 diabetes: canagliflozin, dapagliflozin and empagliflozin...
New data for vedolizumab in UC presented at DDW
24 May 2016 | By Victoria White, Digital Content Producer
Vedolizumab is the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active UC...
Lariam only to be considered as a last resort, says Defence Committee
24 May 2016 | By Victoria White, Digital Content Producer
Lariam, the anti-malarial drug sometimes prescribed to British troops, should be considered only as a drug of last resort, says the Defence Committee...
New data show clinical benefit of Adacolumn in UC
24 May 2016 | By Victoria White, Digital Content Producer
Prof. Dr. Axel Dignass said the data show that Adacolumn provided clinical benefit in steroid-dependent patients with UC with previous failure to biologics...
Champix label updated to include new safety and efficacy data
24 May 2016 | By Victoria White, Digital Content Producer
As part of the update, the black triangle symbol, indicating that additional safety monitoring for Champix in the UK was required, has been removed...
EC grants conditional approval to daratumumab in multiple myeloma
23 May 2016 | By Victoria White, Digital Content Producer
Daratumumab is the first CD38-directed mAb approved in Europe. It binds to CD38, a signalling molecule expressed on the surface of multiple myeloma cells...
